Tizanidne Hydrochloride Capsule
Product Images NDC 67877-612

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 67877-612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

FDA Label Image

Tiz03 (Tiz03)

FDA Label Image

Tiz04 (Tiz04)

The text describes the improvement in Ashworth score after taking Tizanidine, with a mean dose of 26.8 mg, at different stages of the study, including the end of titration, end of maintenance, and endpoint.*

FDA Label Image

Tiz05new (Tiz05new)

This is a description of Tizanidine capsules marketed under the trademark Zanaflex by Acorda Therapeutics Inc. It contains 2.29 mg Tizanidine Hydrochloride per capsule, which is equivalent to 2 mg Tizanidine base. The usual dosage is provided in the package insert. It is manufactured by Alkem Laboratories Ltd in Mumbai, India and distributed by Ascend Laboratories LLC in Parsippany, NJ. The capsules are not interchangeable with Tizanidine or Zanaflex tablets. It comes in a bottle containing 150 capsules, and should be stored at 25°C (77°F).*

FDA Label Image

Tiz06new (Tiz06new)

Tizanidine Hydrochloride Capsules is a prescription medication that is not interchangeable with tizanidine tablets or Zanaflex tablets. Each capsule contains 2.29 mg tizaridine hydrochloride equivalent to 2mg tzanidine base. It is manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC. The medication should be stored at 25°C (7°F); excursions permitted 1 15 to 30°C (59 to 86°F) {see USP Controlled Room Temperature]. The usual dosage should be referred to the package insert for complete prescribing information.*

FDA Label Image

Tiz07 (Tiz07)

This is a prescription medication called Tizanidine Hydrochloride Capsule, containing 2 mg of the active ingredient. It is manufactured for a company called Ascend Laboratories, LLC and produced in India. The lot number and expiration date are provided.*

FDA Label Image

Tiz08new (Tiz08new)

This appears to be the label and packaging information for a medication called Tizanidine Hydrochloride. It contains warnings and instructions for use, including dosages, storage information, and details on its manufacturing and distribution. The label also notes that the medication is "Rx Only" and that it should be kept out of reach of children.*

FDA Label Image

Tiz09new (Tiz09new)

Tizanidine Hydrochloride Capsules by ASCEND Laboratories contain 4.58 g tizanidine hydrochloride in 10 capsules per unit dose pack. These capsules are not to be interchanged with tizanidine tablets or Zanaflex™ tablets. The capsules must be stored between 15°C to 30°C (59°F to 86°F) and kept out of reach of children. Usual dosage and prescribing information is available in the package insert. These capsules are manufactured by Alkem Laboratories Limited in Mumbai, India and distributed in the United States by Ascend Laboratories LLC based in Parsippany, NJ.*

FDA Label Image

Tiz10 (Tiz10)

This is a prescription medicine known as Tizanidine Hydrochloride Capsule, indicated for certain muscle spasms. It is manufactured and distributed by Ascend Laboratories, LLC in India. The label has lot and expiration date information.*

FDA Label Image

Tiz11new (Tiz11new)

This text is a label of a medication that contains 6.87 mg of tizanidine hydrochloride equivalent to 6 mg of tizanidine base. The medication is stored at 25°C, and should be kept out of reach of children. It includes prescribing information and manufacturing/distribution details. It has a barcode for batch and production details.*

FDA Label Image

Tiz12new (Tiz12new)

This is the description for Tizanidine Hydrochloride Capsules. This medicine is available in the form of 10 capsules (1 X 10 unit dose) manufactured by Alkem Laboratories Ltd., Mumbai and distributed by Ascend Laboratories, LLC Parsippany, NJ. It is not interchangeable with tizanidine tablets or Zanaflex™* tablets. Side effects and complete prescribing information are provided in the package insert. The usual dosage is based on medical advice. Store it at 25°C (77°F) and keep it out of reach of children. The drug contains 6.87 mg Tizanidine hydrochloride equivalent to 6 mg Tizanidine base.*

FDA Label Image

Tiz13 (Tiz13)

This is a prescription medication for Tizanidine Hydrochloride Capsule with a base of 6mg. The manufacturer is Ascend Laboratories, LLC and the product is made in India. The lot number and expiration date are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.